RW

Riku Walia

Active Director Director DIN 08993288
DIN 08993288 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Riku Walia

Data last updated:

Riku Walia is a Director at Bioconnect Pharma Private Limited (since 2020). The company operates in Pharma. Bioconnect Pharma Private Limited reported revenue of ₹67.3 Lakh (FY 2024).

DIN 08993288
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 2020
Oldest Company Age 7 yrs
Largest company Bioconnect Pharma Private Limited · ₹67.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioconnect Pharma Private Limited U51909CH2018PTC042263
Director01 Dec 20202018₹67.3 Lakh (FY 2024)Active

Board colleagues of Riku Walia

NameDINCompanyDesignation
Pawan Walia08281453Bioconnect Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bioconnect Pharma Private Limited
Premium access

Shareholding and investment profile for Riku Walia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Riku Walia

Riku Walia currently holds 1 directorship: Bioconnect Pharma Private Limited (Director, since 01 Dec 2020, revenue ₹67.3 Lakh (FY 2024)).

Riku Walia was first appointed on 01 Dec 2020 as Director at Bioconnect Pharma Private Limited.

The current boards of Riku Walia's companies include Pawan Walia (Bioconnect Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available